These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21278248)

  • 1. What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus?
    King RI; Florkowski CM; Yeo J; Walmsley TA; Shand BI; Scott RS; George PM
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):166-9. PubMed ID: 21278248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.
    Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A
    Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
    Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients.
    Zeljkovic A; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Peco-Antic A; Kostic M; Vasic D; Spasic S
    Transpl Int; 2011 Nov; 24(11):1094-102. PubMed ID: 21848901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
    Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
    Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
    Shoji T; Hatsuda S; Tsuchikura S; Shinohara K; Kimoto E; Koyama H; Emoto M; Nishizawa Y
    Atherosclerosis; 2009 Feb; 202(2):582-8. PubMed ID: 18492490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome.
    Doi SA; Abbas JM; Parkinson L; Chakraborty J; Akanji AO
    Am J Clin Pathol; 2008 May; 129(5):802-10. PubMed ID: 18426742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small, dense LDL cholesterol and apolipoprotein B: relationship with serum lipids and LDL size.
    Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Memon L; Spasic S
    Atherosclerosis; 2009 Dec; 207(2):496-501. PubMed ID: 19632678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S; Tsunoda F; Hirano T; Iso Y; Suzuki H; Geshi E; Katagiri T
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
    Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.